EPAS1 and diabetes mellitus: In earlier studies, acute hepatocyte-specific HIF-P4H-3 loss has been shown to improve insulin sensitivity and ameliorate diabetes by specifically stabilizing HIF2α and the upregulation of Irs2 transcription and insulin-stimulated protein kinase B activation (17).